Study finds how malaria parasites sense stress and switch to transmission mode

The malaria parasite Plasmodium falciparum spends part of its life cycle multiplying inside human red blood cells, and part of it preparing to move on to a mosquito. To make that jump, some parasites transform into sexual forms called gametocytes, which are the only stage that mosquitoes can pick up and pass to another person. Every generation, the parasite faces a trade-off: keep multiplying to sustain the infection in its current host, or divert some of its population into gametocytes to secure a route out.

Researchers led by the Barcelona Institute for Global Health (ISGlobal) report that P. falciparum can sense when conditions turn hostile — a fever spike, a shortage of nutrients, or exposure to an antimalarial drug — and respond by making more gametocytes. Producing transmissible forms costs the parasite the chance to keep expanding in the current host, but it improves the odds of reaching a new one if the current host environment is becoming unfavourable. What has been missing for decades, according to the study, is an explanation of the molecular chain of events linking a stressful environment to the decision to convert.

The findings, published in Nature Microbiology, describe a shared pathway that responds to several distinct kinds of stress. The work was coordinated by Alfred Cortés at ISGlobal, with Elisabet Tintó as first author.

To find the mechanism, the research team exposed cultured parasites separately to three different stresses: a shortage of nutrients, treatment with the antimalarial drug dihydroartemisinin (DHA), and a simulated fever. They then tracked which genes switched on, which proteins increased, and how the parasite's chromatin — the packaging that wraps around DNA and controls which genes can be read — was reorganised in each case. The same experiments were repeated in parasites whose relevant genes had been altered, to see which components were actually necessary for the response.

All three stresses converged on the same regulatory route, activating the same two genes: gdv1 and ap2-g, both known from earlier work to be central to starting gametocyte formation. The study identifies a protein called AP2-HS as the hub that receives these different stress signals and forwards them into that shared pathway. When AP2-HS detects stressful conditions, it switches on GDV1, which in turn starts the conversion process into gametocytes; AP2-HS also activates other mechanisms that help the parasite survive stress more broadly.

Deleting the ap2-hs gene had a stark effect: parasites completely lost the ability to form gametocytes, even when exposed to fever, DHA, or nutrient shortage. Whatever few gametocytes tried to develop failed to survive. That outcome marks AP2-HS as a required piece of the pathway, not just a contributing one.

The study also describes a feedback loop that keeps the response from running too long. Once GDV1 is switched on, it triggers conversion into gametocytes, but it simultaneously induces an RNA molecule called gdv1-as, which represses GDV1 itself. The researchers describe this as a braking system that allows a fast reaction to stress while preventing GDV1 from staying active longer than necessary, which the study says could otherwise be lethal to the parasite.

This adds detail to a broader picture that other researchers have been building for years. Earlier work has already shown that antimalarial drug exposure can shift gametocyte production, though results have been inconsistent: one study using DHA found that pulsing the drug onto parasites at one stage of their growth cycle roughly quadrupled sexual conversion, while pulsing an earlier stage produced no such increase. Reviews of the field have likewise noted that malaria parasites can adjust how much they invest in transmission versus continued replication depending on host conditions, a trade-off framed in evolutionary terms as balancing within-host survival against between-host spread.

The ISGlobal team frames its result as resolving a long-standing question: how the parasite adapts its life cycle to a changing environment and produces the transmissible forms it needs to persist across a population. Establishing AP2-HS as a shared control point for three separate stresses is a more complete mechanistic account than existed before, according to the study.

Other sources in this area show the picture is not simple. One study exposing parasites to DHA found the drug's effect on sexual conversion depended heavily on which developmental stage was exposed, and found no additional increase in conversion when DHA was applied to cultures already stimulated by choline depletion, suggesting the pathways stress signals travel through are not identical in every case. That earlier work also noted that past studies using drugs such as chloroquine or DHA had produced inconsistent results on sexual conversion, some finding increases and others finding none, a discrepancy attributed partly to methodological differences and partly to a genuinely complex relationship between drug type, dose, and parasite stage. The new AP2-HS findings come from experiments in parasite cultures combining genomic, epigenomic, transcriptomic and proteomic analysis; the study does not describe testing this mechanism directly in human infections.